Terms: = Breast cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
71 results:
1. HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
Baez-Navarro X; van den Ende NS; Nguyen AH; Sinke R; Westenend P; van Brakel JB; Stobbe C; Westerga J; van Deurzen CHM
Breast Cancer Res; 2024 Mar; 26(1):41. PubMed ID: 38468323
[TBL] [Abstract] [Full Text] [Related]
2. breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
Bae SJ; Kim HJ; Kim HA; Ryu JM; Park S; Lee EG; Im SA; Jung Y; Park MH; Park KH; Kang SH; Park E; Kim SY; Lee MH; Kim LS; Lee A; Noh WC; Gwark S; Kim S; Jeong J
Int J Surg; 2024 Feb; 110(2):934-942. PubMed ID: 38000057
[TBL] [Abstract] [Full Text] [Related]
3. Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study.
Li Y; Tong Z; Wu X; Ouyang Q; Cai L; Li W; Yu Z; Han Z; Wang X; Li M; Wang H; Li L; Yang J; Niu Z; Wang Q; Xu B
Int J Cancer; 2023 Nov; 153(10):1809-1818. PubMed ID: 37543965
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence.
Zhou D; Li M; Xu F; Zheng Q; Lu Q; Hong R; Wang S
Ann Med; 2023 Dec; 55(1):2232299. PubMed ID: 37431586
[TBL] [Abstract] [Full Text] [Related]
5. Low Serum Vitamin D Associated With Increased Tumor Size and Higher Grade in Premenopausal Canadian Women With breast cancer.
Manocha A; Brockton NT; Cook L; Kopciuk KA
Clin Breast Cancer; 2023 Aug; 23(6):e368-e376. PubMed ID: 37357130
[TBL] [Abstract] [Full Text] [Related]
6. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract] [Full Text] [Related]
7. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
Sun TH; Lu ZN; Song HT; Sun G
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
[No Abstract] [Full Text] [Related]
8. Association Between Aromatase Inhibitors and Myocardial Infarction Morbidity in Women With breast cancer: A Meta-Analysis of Observational Studies.
Sun JC; Sun ZF; He CJ; Zhai CL; Qian G
Cancer Control; 2022; 29():10732748221132512. PubMed ID: 36346929
[TBL] [Abstract] [Full Text] [Related]
9. breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors.
Freedman RA; Ko NY; Lederman RI; Gagnon H; Fikre T; Gundersen DA; Revette AC; Odai-Afotey A; Kantor O; Hershman DL; Crew KD; Keating NL
Breast Cancer Res Treat; 2022 Dec; 196(3):623-633. PubMed ID: 36220997
[TBL] [Abstract] [Full Text] [Related]
10. Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade.
Kobayashi T; Iwama S; Yamagami A; Yasuda Y; Okuji T; Ito M; Zhou X; Ando M; Onoue T; Miyata T; Sugiyama M; Hagiwara D; Suga H; Banno R; Hase T; Morise M; Ito T; Kikumori T; Inoue M; Ando Y; Masuda N; Kawashima H; Hashimoto N; Arima H
J Clin Endocrinol Metab; 2022 Sep; 107(10):e4115-e4123. PubMed ID: 35918067
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of the Na
Shandell MA; Capatina AL; Lawrence SM; Brackenbury WJ; Lagos D
J Biol Chem; 2022 Mar; 298(3):101707. PubMed ID: 35150740
[TBL] [Abstract] [Full Text] [Related]
12. breast conservation surgery (BCS) for breast cancer in a resource limited country - Are we upto the challenge!
Javed N; Rehman B; Iqbal E; Afzal S; Jamal A; Parvaiz MA
J Pak Med Assoc; 2021 Dec; 71(12):2748-2754. PubMed ID: 35150532
[TBL] [Abstract] [Full Text] [Related]
13. Delay in the diagnosis and treatment of breast cancer in Vietnam.
Nguyen SM; Nguyen QT; Nguyen LM; Pham AT; Luu HN; Tran HTT; Tran TV; Shu XO
Cancer Med; 2021 Nov; 10(21):7683-7691. PubMed ID: 34664428
[TBL] [Abstract] [Full Text] [Related]
14. Opportunities for Improvement in the Administration of Neoadjuvant Chemotherapy for T4 breast cancer: A Comparison of the U.S. and Nigeria.
Romanoff A; Olasehinde O; Goldman DA; Alatise OI; Constable J; Monu N; Knapp GC; Odujoko O; Onabanjo E; Adisa AO; Arowolo AO; Omisore AD; Famurewa OC; Anderson BO; Gemignani ML; Kingham TP
Oncologist; 2021 Sep; 26(9):e1589-e1598. PubMed ID: 33955123
[TBL] [Abstract] [Full Text] [Related]
15. A decade of change: Trends in the practice of cytopathology at a tertiary care cancer centre.
Dinarvand P; Liu C; Roy-Chowdhuri S
Cytopathology; 2021 Sep; 32(5):604-610. PubMed ID: 33792972
[TBL] [Abstract] [Full Text] [Related]
16. Survival of breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early breast cancer.
Kim H; Lee SB; Nam SJ; Lee ES; Park BW; Park HY; Lee HJ; Kim J; Chung Y; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH
Ann Surg Oncol; 2021 Sep; 28(9):5039-5047. PubMed ID: 33492542
[TBL] [Abstract] [Full Text] [Related]
17. Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma.
Sato Y; Nakano K; Fukuda N; Wang X; Urasaki T; Ohmoto A; Yunokawa M; Ono M; Tomomatsu J; Hayakawa K; Funauchi Y; Tanizawa T; Ae K; Matsumoto S; Takahashi S
Anticancer Res; 2021 Jan; 41(1):527-532. PubMed ID: 33419852
[TBL] [Abstract] [Full Text] [Related]
18. Spectrochemical analysis of liquid biopsy harnessed to multivariate analysis towards breast cancer screening.
Freitas DLD; Câmara IM; Silva PP; Wanderley NRS; Alves MBC; Morais CLM; Martin FL; Lajus TBP; Lima KMG
Sci Rep; 2020 Jul; 10(1):12818. PubMed ID: 32733086
[TBL] [Abstract] [Full Text] [Related]
19. The effect of treatment on patient-reported distress after breast cancer diagnosis.
Fayanju OM; Yenokyan K; Ren Y; Goldstein BA; Stashko I; Power S; Thornton MJ; Marcom PK; Hwang ES
Cancer; 2019 Sep; 125(17):3040-3049. PubMed ID: 31120575
[TBL] [Abstract] [Full Text] [Related]
20. Patterns of Dual-Specific Phosphatase 4 mRNA Expression Before and after Neoadjuvant Chemotherapy in breast cancer.
Prihantono P; Usman AN; Binekada C; Hatta M; Islam AA
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1051-1055. PubMed ID: 31030473
[TBL] [Abstract] [Full Text] [Related]
[Next]
